Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgery

Bone morphogenetic proteins (BMPs) are capable of promoting bone healing and even induce de novo osteogenesis. Their clinical application in spinal fusion surgery has recently increased in popularity. This is especially true for the use of BMPs in combination with artificial bone substitutes that have the capability to replace autologous bone graft, which can be associated with severe harvesting complications. This review will examine the use of BMP-2 and BMP-7 as commercially available products that have proven their osteoinductive capacity in spinal fusion. We will perform an overview of the literature for scientific evidence supporting the use of these new technologies. Despite their high osteoinductive potency, the use of BMPs does not replace proper surgical stabilization in spinal fusion. Safety issues with BMPs are osteoclast activation, postoperative swelling and hyperostosis. Despite these issues, manufacturers continue to expend more effort concerning proper application, dosage and carriers for these devices for spinal fusion, both presently and in the future.

[1]  Hak-Sun Kim,et al.  Simple Carrier Matrix Modifications Can Enhance Delivery of Recombinant Human Bone Morphogenetic Protein-2 for Posterolateral Spine Fusion , 2003, Spine.

[2]  C. Carstens,et al.  Gesundheitsökonomische Überlegungen für den Einsatz des Knochenwachstumsfaktors BMP-2 in der Wirbelsäulenchirurgie für das deutsche Gesundheitssystem , 2006 .

[3]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[4]  C. Branch,et al.  Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. , 2004, The spine journal : official journal of the North American Spine Society.

[5]  S. L. Griffith,et al.  A Prospective Randomized Multicenter Clinical Evaluation of an Anterior Cervical Fusion Cage , 2000, Spine.

[6]  D. Polly,et al.  Computerized tomography evaluation of a resorbable implant after transforaminal lumbar interbody fusion. , 2004, Neurosurgical focus.

[7]  David S Baskin,et al.  A Prospective, Randomized, Controlled Cervical Fusion Study Using Recombinant Human Bone Morphogenetic Protein-2 With the CORNERSTONE-SR™ Allograft Ring and the ATLANTIS™ Anterior Cervical Plate , 2003, Spine.

[8]  W. Hutton,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.

[9]  T. Lanman,et al.  Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly(L-lactide-co-D,L-lactide) bioresorbable implants. , 2004, Neurosurgical focus.

[10]  Fan Liu,et al.  Promoting lumbar spinal fusion by adenovirus-mediated bone morphogenetic protein-4 gene therapy. , 2007, Chinese journal of traumatology = Zhonghua chuang shang za zhi.

[11]  A. Minamide,et al.  Experimental study of carriers of bone morphogenetic protein used for spinal fusion , 2004, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[12]  R. Crystal,et al.  Combined Bone Morphogenetic Protein‐2 and −7 Gene Transfer Enhances Osteoblastic Differentiation and Spine Fusion in a Rodent Model , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  T. Albert,et al.  The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. , 2008, The spine journal : official journal of the North American Spine Society.

[14]  S. Cook,et al.  Osteogenic protein-1: biology and applications. , 1996, Clinical orthopaedics and related research.

[15]  P. Aspenberg,et al.  Randomized Radiostereometric Study Comparing Osteogenic Protein-1 (BMP-7) and Autograft Bone in Human Noninstrumented Posterolateral Lumbar Fusion: 2002 Volvo Award in Clinical Studies , 2002, Spine.

[16]  S. Boden,et al.  Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. , 1997, Journal of spinal disorders.

[17]  Paramore Cg.  The safety of OP-1 for lumbar fusion with decompression-- a canine study. , 1999 .

[18]  J. Lane,et al.  Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the Spine , 2002, Spine.

[19]  Joseph D. Smucker,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 as an Adjunct in Posterolateral Lumbar Spine Fusion: A Prospective CT-Scan Analysis at One and Two Years , 2006, Journal of spinal disorders & techniques.

[20]  W. Dhert,et al.  The Incidence of Donor Site Pain After Bone Graft Harvesting From the Posterior Iliac Crest May Be Overestimated: A Study on Spine Fracture Patients , 2007, Spine.

[21]  M. Hadley,et al.  The safety of OP-1 for lumbar fusion with decompression-- a canine study. , 1999, Neurosurgery.

[22]  R. Pietrobon,et al.  Prospective Analysis of Incidence and Risk Factors of Dysphagia in Spine Surgery Patients: Comparison of Anterior Cervical, Posterior Cervical, and Lumbar Procedures , 2004, Spine.

[23]  B. Barnes,et al.  Lower Dose of rhBMP-2 Achieves Spine Fusion When Combined With an Osteoconductive Bulking Agent in Non-human Primates , 2005, Spine.

[24]  R. Capanna,et al.  Clinical applications of BMPs. , 2005, Injury.

[25]  S. Glassman,et al.  Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.

[26]  S. Cook,et al.  In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal Fusions , 1994, Spine.

[27]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[28]  R. Balderston,et al.  Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2 , 2002, Spine.

[29]  S. Chubinskaya,et al.  Safety of Epidural Administration of Osteogenic Protein-1 (OP-1/BMP-7): Behavioral and Macroscopic Observation , 2007, Spine.

[30]  C. Shaffrey,et al.  Iliac Crest Bone Graft Donor Site Pain After Anterior Lumbar Interbody Fusion: A Prospective Patient Satisfaction Outcome Assessment , 2005, Journal of spinal disorders & techniques.

[31]  J. Reynolds,et al.  Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. , 2007, The spine journal : official journal of the North American Spine Society.

[32]  M. Boakye,et al.  Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. , 2005, Journal of neurosurgery. Spine.

[33]  Thomas Mittlmeier,et al.  Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors. , 2002, Journal of neurosurgery.

[34]  R. Delamarter,et al.  An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. , 2006, The spine journal : official journal of the North American Spine Society.

[35]  J. Fischgrund,et al.  The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.

[36]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[37]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[38]  K. Bulsara,et al.  Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. , 2005, Journal of neurosurgery. Spine.

[39]  H. Terai,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2 Delivered by a Synthetic Polymer and &bgr;-Tricalcium Phosphate in a Rabbit Model , 2005, Spine.

[40]  D. Togawa,et al.  A Prospective Randomized Study of Posterolateral Lumbar Fusion Using Osteogenic Protein-1 (OP-1) Versus Local Autograft With Ceramic Bone Substitute: Emphasis of Surgical Exploration and Histologic Assessment , 2006, Spine.

[41]  John R. Johnson,et al.  Posterolateral lumbar spine fusion with INFUSE bone graft. , 2007, The spine journal : official journal of the North American Spine Society.

[42]  I Harvey,et al.  Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. , 2007, Health technology assessment.

[43]  S. Glassman,et al.  Clinical Outcomes and Fusion Success at 2 Years of Single-Level Instrumented Posterolateral Fusions With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix Versus Iliac Crest Bone Graft , 2006, Spine.